Transformed Indolent B-cell Non-hodgkin Lymphoma to Diffuse Large B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Transformed Indolent B-cell Non-hodgkin Lymphoma to Diffuse Large B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Tegavivint for Treating Patients With Relapsed or Refractory Large B-Cell Lymphoma [Phase 1]
Phase 1 clinical trial update for tegavivint in relapsed or refractory diffuse large B-cell lymphoma, with ongoing recruitment.